Recalls / Firms / InvaGen Pharmaceuticals, Inc.
InvaGen Pharmaceuticals, Inc.
11 FDA drug recalls on record — 1 Class I.
| Date | Class | Drug | Status |
|---|---|---|---|
| 2023-11-17 | Class I | Vigabatrin | Completed |
| 2020-05-14 | Class III | Gabapentin | Terminated |
| 2019-06-12 | Class III | Testosterone | Terminated |
| 2019-03-22 | Class II | Testosterone Cypionate | Terminated |
| 2019-03-22 | Class II | Testosterone Cypionate | Terminated |
| 2019-03-22 | Class II | Testosterone Cypionate | Terminated |
| 2018-10-03 | Class III | Amlodipine Besylate | Terminated |
| 2018-09-06 | Class III | Bupropion Hydrochloride | Terminated |
| 2018-03-15 | Class III | Bupropion Hydrochloride (sr) | Terminated |
| 2018-03-15 | Class III | Bupropion Hydrochloride (sr) | Terminated |
| 2018-03-05 | Class III | Decitabine for Injection, 50mg per vial, Rx only, Manufactured by: Cipla Ltd., Verna Goa, | Terminated |